Skip to content

Lisa Trattner, BSc

Scientific Associate

Research statement

My research focuses on studying the nature of aggressive squamous cell carcinoma which develops especially in patients with recessive dystrophic epidermolysis bullosa. In particular, I am working on the development of an immunetherapy that exploits a pre-existing immunity against common childhood pathogens and redirects it againts tumor cells.




Personal interests

I enjoy being outside in nature, preferably in the mountains. In addition to my scientific education I am a passionate musician and zither player.




Curriculum Vitae Lisa Trattner

Professional career

Since 2021
Scientific Associate at the EB House



Since 2018
Master studies
Molecular Medicine, University of Vienna

in Medical and Pharmaceutical Biotechnology, IMC FH Krems
"Investigating the potential use of metformin in the therapy of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa"
Working Group at the EB House: Dr. Josefina Piñón Hofbauer, Dr. Christina Guttmann-Gruber


Additional qualifications

2017 Laboratory Animal Science – Basic Course Rodents (Universität Salzburg)
2020 Laboratory Animal Science – Basic Course Zebrafish (Karolinska Institutet)


Original Articles

  1. Woess K, Sun Y, Morio H, Stierschneider A, Kaufmann A, Hainzl S, Trattner L, Kocher T, Tockner B, Leb-Reichl V, Steiner M, Brachtl G, South AP, Bauer JW, Reichelt J, Furihata T, Wally V, Koller U, Piñón Hofbauer J, Guttmann-Gruber C. Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer. International journal of molecular sciences 2022;23.
Back to main navigation